Study comparing Cabazitaxel/Prednisone in combination with Custirsen (OGX-011) to Cabazitaxel/Prednisone for second-line chemotherapy in men with metastatic castrate resistant prostate cancer

Project: Research

Project Details

StatusFinished
Effective start/end date1/10/1230/06/14